Joel Rurik is a postdoctoral fellow in Dr. Marcus Buggert’s laboratory at Karolinska Institutet studying human tissue resident, memory T cells and developing mRNA-based immunotherapies. Joel completed his PhD in Dr. Jonathan A. Epstein’s laboratory at Perelman School of Medicine at the University of Pennsylvania, where he developed novel RNA delivery technologies to generate immuno-medicine therapeutics in vivo to treat fibrosis and how the cardiac mesenchyme interacts with the immune system. Long-term, Joel is fascinated by the adaptive immune system and wants to leverage these powerful cells for human health.